Toggle navigation
Campus Access
About MPG.eBooks
Skip to content
Search Tips
Home
>
Search: ("motet" OR ((("motets" OR "notes") OR "notes") OR "votes"))
Language
English
Deutsch
Español
Français
Italiano
日本語
Nederlands
Português
Português (Brasil)
中文(简体)
中文(繁體)
Türkçe
עברית
Gaeilge
Cymraeg
Ελληνικά
Català
Euskara
Русский
Čeština
Suomi
Svenska
polski
Dansk
slovenščina
اللغة العربية
বাংলা
Galego
Tiếng Việt
Hrvatski
हिंदी
All Fields
Title
Person
Topic
ISBN/ISSN
Year
Collection
Advanced
Retain my current filters
author_facet:"Canadian Agency for Drugs and Technologies in Health"
Search alternatives
:
"motet" »
"lotet"
,
"mote"
,
"monet"
"motets" »
"lotets"
,
"motes"
,
"monets"
"votes" »
"vote"
Showing
1
-
20
of
37
Search:
'("motet" OR ((("motets" OR "notes") OR "notes") OR "votes"))'
,
query time: 0.16s
Book List
0
Sort:
Relevance
Year Descending
Year Ascending
Author
Title
Read Now
1
Glyburide, gliclazide, or glimepiride for elderly patients with type 2 diabetes : a review of the clinical effectiveness and safety - an update
Published 2015
Canadian Agency for Drugs and Technologies in Health
“
...
noted
. Thus, this update will expand on the work of the previous CADTH reports to further investigate...
”
Read Now
2
Glyburide, gliclazide, or glimepiride for elderly patients with type 2 diabetes : a review of the clinical effectiveness and safety - an update
Published 2015
Canadian Agency for Drugs and Technologies in Health
“
...
noted
. Thus, this update will expand on the work of the previous CADTH reports to further investigate...
”
Read Now
3
Pharmacoeconomic review report: Budesonide (Jorveza) : (AVIR Pharma Inc.) : indication : for the induction of clinicopathologic remission in adults with eosinophilic esophagitis
Published 2020
Canadian Agency for Drugs and Technologies in Health
“
... component. The CADTH clinical review also
noted
uncertainty in the meaningfulness of the observed...
”
Read Now
4
Alogliptin (Nesina) for type 2 diabetes mellitus
Published 2015
Canadian Agency for Drugs and Technologies in Health
“
.... Of
note
, the Canadian Drug Expert Committee recommendations for the existing DPP-4 inhibitors have...
”
Read Now
5
Alogliptin (Nesina) for type 2 diabetes mellitus
Published 2015
Canadian Agency for Drugs and Technologies in Health
“
.... Of
note
, the Canadian Drug Expert Committee recommendations for the existing DPP-4 inhibitors have...
”
Read Now
6
Respiratory precautions for protection from bioaerosols or infectious agents : a review of the clinical effectiveness and guidelines
Published 2014
Canadian Agency for Drugs and Technologies in Health
“
...). As the Canadian Biosafety Standards and Guidelines
note
: "Using the wrong respirator or misusing one can...
”
Read Now
7
Rituximab maintenance therapy for the treatment and management of rheumatoid arthritis : a review of clinical effectiveness
by
Singh, Kavita
,
McCormack, Suzanne
Published 2018
CADTH
“
.... Rituximab was given a positive recommendation, however the Committee
noted
that the evidence for repeated...
”
Read Now
8
Dual antiplatelet therapy following percutaneous coronary intervention: Clinical and economic impact of standard versus extended duration : project protocol
Published 2018
Canadian Agency for Drugs and Technologies in Health
“
... of individual P2Y12 inhibitors. Of
note
, the patient subgroups were selected based on the clinical components...
”
Read Now
9
Dual antiplatelet therapy following percutaneous coronary intervention: Clinical and economic impact of standard versus extended duration : project protocol
Published 2018
Canadian Agency for Drugs and Technologies in Health
“
... of individual P2Y12 inhibitors. Of
note
, the patient subgroups were selected based on the clinical components...
”
Read Now
10
Rituximab maintenance therapy for the treatment and management of rheumatoid arthritis : a review of clinical effectiveness
by
Singh, Kavita
,
McCormack, Suzanne
Published 2018
CADTH
“
.... Rituximab was given a positive recommendation, however the Committee
noted
that the evidence for repeated...
”
Read Now
11
Dual antiplatelet therapy following percutaneous coronary intervention: Clinical and economic impact of standard versus extended duration : recommendations
Published 2019
Canadian Agency for Drugs and Technologies in Health
“
... is ongoing about the optimal duration of DAPT. Of
note
, patient characteristics may be an important factor...
”
Read Now
12
Dual antiplatelet therapy following percutaneous coronary intervention: Clinical and economic impact of standard versus extended duration : recommendations
Published 2019
Canadian Agency for Drugs and Technologies in Health
“
... is ongoing about the optimal duration of DAPT. Of
note
, patient characteristics may be an important factor...
”
Read Now
13
Pharmacoeconomic review report: Tildrakizumab (Ilumya) : (Sun Pharma Global FZE) : indication : for the treatment of adult patients with moderate-to-severe plaque psoriasis who are...
Published 2021
Canadian Agency for Drugs and Technologies in Health
“
... at a WTP threshold of $50,000 per QALY. It should be
noted
there is significant uncertainty around...
”
Read Now
14
Alogliptin plus metformin (Kazano) for type 2 diabetes mellitus
Published 2015
Canadian Agency for Drugs and Technologies in Health
“
... criteria be modified to reflect the indication under review. Of
note
, Canadian Expert Drug Advisory...
”
Read Now
15
Canadian journal of health technologies
Published 2021
CADTH
Read Now
16
Topical antibiotics for infected wounds : review of the clinical effectiveness and guidelines
by
Cowling, Tara
,
Jones, Sarah
Published 2017
Canadian Agency for Drugs and Technologies in Health
“
..., many of them
noting
the limitations of the current literature. For instance, some authors suggest using...
”
Read Now
17
Denosumab versus zoledronic acid for men with osteoporosis : a review of clinical effectiveness and guidelines
Published 2016
Canadian Agency for Drugs and Technologies in Health
“
...)
noted
that at the time of the CDR review, there were no direct comparisons of denosumab with other...
”
Read Now
18
Topical antibiotics for infected wounds : review of the clinical effectiveness and guidelines
by
Cowling, Tara
,
Jones, Sarah
Published 2017
Canadian Agency for Drugs and Technologies in Health
“
..., many of them
noting
the limitations of the current literature. For instance, some authors suggest using...
”
Read Now
19
CADTH health technology assessment
Published 2015
Canadian Agency for Drugs and Technologies in Health
Read Now
20
CADTH health technology review
Published 2021
Canadian Agency for Drugs and Technologies in Health
1
2
Back
Narrow Search
Remove Filters
Clear Filter
Author: Canadian Agency for Drugs and Technologies in Health
Year of Publication
From:
To:
Classification
610 - Medicine & health
17
330 - Economics
12
600 - Technology
5
700 - The arts; fine & decorative arts
5
140 - Specific philosophical schools
2
Language
English
37
Collection
National Center for Biotechnology Information
37
Author
Canadian Agency for Drugs and Technologies in Health
Cowling, Tara
2
Jones, Sarah
2
McCormack, Suzanne
2
Singh, Kavita
2
Search Tools
Get RSS Feed
Share Search
https://ebooks.mpdl.mpg.de/ebooks/Search/Results?filter%5B%5D=author_facet%3A%22Canadian+Agency+for+Drugs+and+Technologies+in+Health%22&lookfor=%28%22motet%22+OR+%28%28%28%22motets%22+OR+%22notes%22%29+OR+%22notes%22%29+OR+%22votes%22%29%29&type=AllFields
Send by Email
×
Loading...